3 results match your criteria: "and Institute of Cancer Epidemiology[Affiliation]"

Declining Bowel Cancer Incidence and Mortality in Germany.

Dtsch Arztebl Int

February 2016

Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ, Deutsches Krebsforschungszentrum), Heidelberg, Germany, Division of Preventive Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg, Germany, German Consortium for Translational Cancer Research (DKTK, Deutsches Konsortium für Translationale Krebsforschung), German Cancer Research Center (DKFZ), Heidelberg, Germany, Saarland Cancer Registry, Saarbrücken, Germany, Institute of Social Medicine and Epidemiology, University Hospital Schleswig Holstein, Campus Lübeck and Institute of Cancer Epidemiology, University of Lübeck.

Background: In October 2002, screening colonoscopy from age 55 onward was introduced as part of the German national statutory cancer screening program. Screening colonoscopy is intended to lower both the mortality and the incidence of bowel cancer by enabling the detection and removal of precursor lesions.

Methods: The authors studied trends in bowel cancer incidence and mortality in Germany from 2003 to 2012 on the basis of data from the epidemiological cancer registries and from cause-of-death statistics.

View Article and Find Full Text PDF

Although numerous epidemiologic studies have examined the long-term safety of silicone breast implants during the past decade, there is a relative lack of surveillance data on short-term health effects and complications following cosmetic surgery of the breast. The Danish Registry for Plastic Surgery of the Breast, established in May of 1999, provides plastic surgeons with a nationwide system for the collection of preoperative, perioperative, and postoperative data on women undergoing breast implantation, breast reduction, or mastopexy. The purpose of the Registry is to examine short-term and, eventually, long-term local complications and possible health effects, and to contribute to an ongoing evaluation of surgical results and surveillance of the products.

View Article and Find Full Text PDF

Objective: To assess the risk of borderline ovarian cancer among infertile women treated with fertility drugs.

Design: Case-control study.

Setting: Nationwide data obtained from public registers and postal questionnaires.

View Article and Find Full Text PDF